克洛扎诱导的轻松:一个病例报告
Soumitra Das1, Annie Itrat2, Mary Elizabeth Trejo Hernandez3
1Emergency Mental Health, Sunshine Hospital, Melbourne, VIC, Australia.
SAGE open medical case reports
|September 5, 2023
概括
克洛扎平是治疗精神分裂症的有效药物,但可能导致异敏性爱症,这是一种可能危及生命的疾病. 本研究检查了克洛扎的剂量.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 精神分裂症是一种慢性神经精神疾病,用抗精神病药物治疗,尽管治疗耐药性很常见.
- 克洛扎平是一种高效的非典型抗精神病药物,用于治疗耐药的精神分裂症,降低了自杀风险,复发和额外皮拉米德副作用.
- 克洛扎的使用受到不良影响的限制,包括农细胞瘤症,代谢综合征,发作和罕见但严重的eosinophilia.
研究的目的:
- 报告使用克洛札治疗的精神分裂症患者中氨酸的发病率.
- 调查克洛沙剂量与氨酸友爱症的进展及其对末端器官的影响之间的关系.
- 鉴于现有文献的稀缺性,有助于了解克洛扎诱导的氨酸.
主要方法:
- 一个案例研究,一个患有自闭症谱系障碍的精神分裂症患者正在接受克洛扎治疗.
- 与不同剂量的克洛扎相比,对埃奥西诺菲尔和C-反应蛋白水平的分析.
- 数据记录并总结在表格和叙事评论中.
主要成果:
- 该研究记录了埃索诺菲尔和C反应性蛋白水平的变化.
- 有证据表明,克洛扎剂量与埃索诺菲尔和C-反应蛋白水平的变化之间存在相关性.
- 该案例研究提供了关于克洛札剂量的疾病进展模式的见解.
结论:
- 克洛扎诱导的轻松是需要进一步调查的重大问题.
- 了解克洛扎诱导的阳病的进展和管理以及其对末端器官的影响至关重要.
- 需要进行进一步的研究,以制定明确的指导方针来管理克洛扎诱导的异敏.
相关概念视频
01:26Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
342
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
342
02:06Allergic Reactions
27.8K
Overview
27.8K
01:20Antiepileptic Drugs: Potassium Channel Activators
210
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
210
01:28Psychosis and Antipsychotic Drugs: Overview
321
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
321
01:19Antiasthma Drugs: Leukotriene Modifiers
353
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
353